Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Applied and Environmental Microbiology|May 1, 1991
Comparison of representative strains of infectious hematopoietic necrosis virus by serological neutralization and cross-protection assaysH M Engelking, J B Harry, J A LeongNeuropsychologia|March 3, 2023
Brain networks for temporal adaptation, anticipation, and sensory-motor integration in rhythmic human behaviorBronson B Harry, Daniel S Margulies, Marcel Falkiewicz, et al.Journal of the National Medical Association|May 1, 1991
The need for a standard national immunization recordT L Yarboro, B Harry, E Hough, et al.Medical Mycology|February 28, 2002
Transcription initiation of genes associated with azole resistance in Candida albicansJ B Harry, J L Song, C N Lyons, et al.Journal of Virology|November 1, 1994
Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1A Schmitt, J B Harry, B Rapp, et al.Journal of Virology|October 1, 1996
Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformationG W Demers, E Espling, J B Harry, et al.Genes & Development|August 15, 1997
Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoproteinJ O Funk, S Waga, J B Harry, et al.Journal of Cognitive Neuroscience|April 8, 2016
Evidence for Integrated Visual Face and Body Representations in the Anterior Temporal LobesBronson B Harry, Katja Umla-Runge, Andrew D Lawrence, et al.BMJ Open|January 4, 2023
Comparison of the Journey II bicruciate stabilised (JII-BCS) and GENESIS II total knee arthroplasty for functional ability and motor impairment: the CAPAbility, blinded, randomised controlled trialIain McNamara, Valerie Pomeroy, Allan B Clark, et al.Nature Medicine|July 9, 2026
Human embryonic stem cell-derived dopaminergic cells for Parkinson's disease: a phase 1/2 open-label trialG Paul, H Bjartmarz, A Kirkeby, et al.Pageof 5